DcpS Inhibitor Treatment of HEK293T Cells
Corresponding Organization :
Other organizations : Centre hospitalier universitaire de Québec, Université Laval, Hôtel-Dieu de Québec, Pfizer (United States)
Variable analysis
- D156844 DcpS-inh
- RNA expression
- Protein expression
- HEK293T cell line
- Dulbecco modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 5% Penicillin/Streptomycin
- Temperature at 37 °C
- Atmosphere with 5% CO2
- Seeding density of 3 × 10^5 cells per 6-well plate
- Medium change at Day 2
- DMSO as a negative control
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!